Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion
(thrombosis and/or pregnancy morbidity), combined with persistently circulating …

Antiphospholipid antibodies (aPL) are mandatory for the diagnosis but are also a risk factor
for the antiphospholipid syndrome (APS) clinical manifestations. Lupus anticoagulant (LA) …

Background High incidence of thrombosis in COVID‐19 patients indicates a
hypercoagulable state. Hence, exploring the involvement of antiphospholipid antibodies …

Background Antiβ2glycoprotein I (aβ2GPI) and anticardiolipin (aCL) IgG/IgM show
differences in positive/negative agreement and titers between solid phase platforms. Method …

The diagnosis of antiphospholipid syndrome (APS) relies on the detection of
antiphospholipid antibodies (aPL). Currently, lupus anticoagulant (LA), anticardiolipin (aCL) …

Antibodies to phospholipids (aPL) and associated proteins are a hallmark in the diagnosis of
anti-phospholipid syndrome (APS). Those included in the classification criteria are the lupus …

The diagnosis of antiphospholipid syndrome (APS) relies on the detection of circulating
antiphospholipid antibodies (aPL). Currently, lupus anticoagulant (LA), anticardiolipin (aCL) …

Antiphospholipid syndrome (APS) is a hypercoagulation condition associated with the
incidence of heterogenic antiphospholipid antibodies (aPLs), which non-specifically affect …

The place of non-criteria antiphospholipid antibodies (aPLs) in the diagnosis of
antiphospholipid syndrome (APS) is still debatable. The aim of this research was to evaluate …

Background Diagnosis of antiphospholipid syndrome (APS) is based on the positivity of
laboratory criteria antiphospholipid antibodies (aPLs). Test results for aPLs could be …